Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10751
PUT
Cass Information Systems
CASS
$748M
| $104K | ﹤0.01% |
+2,800
| New | +$107K |
|
10752
Tarsus Pharmaceuticals
TARS
$3.04B
| $104K | ﹤0.01% |
5,864
-131,753
| -96% | -$2.33M |
|
10753
CALL
Arvinas
ARVN
$587M
| $104K | ﹤0.01% |
5,300
-18,600
| -78% | -$456K |
|
|
SHCR
10754
PUT
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $104K | ﹤0.01% |
110,600
-100
| -0.1% | -$119 |
|
|
DSL
10755
DoubleLine Income Solutions Fund
DSL
$1.24B
| $104K | ﹤0.01% |
8,863
-24,900
| -74% | -$298K |
|
|
TPIC
10756
DELISTED
TPI Composites
TPIC
| $104K | ﹤0.01% |
39,175
-668,610
| -94% | -$4.09M |
|
10757
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.31M
| $104K | ﹤0.01% |
6,200
+300
| +5% | +$5.6K |
|
10758
AdvisorShares MSOS 2X Daily ETF
MSOX
$58M
| $104K | ﹤0.01% |
+913
| New | +$73.2K |
|
10759
PUT
Rogers Communications
RCI
$19.7B
| $104K | ﹤0.01% |
2,700
+200
| +8% | +$8.39K |
|
|
GAN
10760
CALL
DELISTED
GAN Ltd
GAN
| $104K | ﹤0.01% |
89,300
+1,000
| +1% | +$1.57K |
|
10761
PUT
VanEck Mortgage REIT Income ETF
MORT
$375M
| $103K | ﹤0.01% |
9,100
-9,600
| -51% | -$113K |
|
10762
PUT
Taysha Gene Therapies
TSHA
$1.94B
| $103K | ﹤0.01% |
32,700
+31,600
| +2,873% | +$59K |
|
10763
PUT
Voyager Therapeutics
VYGR
$201M
| $103K | ﹤0.01% |
13,300
+3,500
| +36% | +$32K |
|
10764
PUT
Alector
ALEC
$219M
| $103K | ﹤0.01% |
15,900
+7,300
| +85% | +$47.3K |
|
|
RDNW
10765
PUT
RideNow Group
RDNW
$248M
| $103K | ﹤0.01% |
16,800
-21,200
| -56% | -$171K |
|
|
AL
10766
DELISTED
Air Lease Corp
AL
| $103K | ﹤0.01% |
2,613
-2,119
| -45% | -$87.1K |
|
10767
Fennec Pharmaceuticals
FENC
$411M
| $103K | ﹤0.01% |
13,710
-25,616
| -65% | -$208K |
|
10768
PUT
Protolabs
PRLB
$2.2B
| $103K | ﹤0.01% |
3,900
-4,800
| -55% | -$145K |
|
|
MIXT
10769
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $103K | ﹤0.01% |
18,634
-1,947
| -9% | -$12.5K |
|
10770
CALL
Veracyte
VCYT
$3.32B
| $103K | ﹤0.01% |
4,600
-4,100
| -47% | -$105K |
|
|
DALN
10771
DELISTED
DallasNews
DALN
| $103K | ﹤0.01% |
22,304
+9,262
| +71% | +$40.4K |
|
|
HFRO
10772
Highland Opportunities and Income Fund
HFRO
$400M
| $102K | ﹤0.01% |
+12,743
| New | +$107K |
|
10773
CALL
American Resources Corp
AREC
$308M
| $102K | ﹤0.01% |
61,300
-12,200
| -17% | -$19.5K |
|
10774
PUT
Genmab
GMAB
$19.6B
| $102K | ﹤0.01% |
2,900
-500
| -15% | -$19.1K |
|
10775
PUT
A10 Networks
ATEN
$1.99B
| $102K | ﹤0.01% |
6,800
-22,100
| -76% | -$327K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.